270 related articles for article (PubMed ID: 26062846)
1. Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.
Huang B; Abraham WD; Zheng Y; Bustamante López SC; Luo SS; Irvine DJ
Sci Transl Med; 2015 Jun; 7(291):291ra94. PubMed ID: 26062846
[TBL] [Abstract][Full Text] [Related]
2. Prescription for a pharmacyte.
Hubbell JA
Sci Transl Med; 2015 Jun; 7(291):291fs23. PubMed ID: 26062842
[TBL] [Abstract][Full Text] [Related]
3. Cellular backpackers deliver lymphoma drugs.
Cancer Discov; 2015 Aug; 5(8):786-7. PubMed ID: 26112672
[TBL] [Abstract][Full Text] [Related]
4. Sanazole directed targeting of silver nanoparticle drug complex to tumor mass: a preclinical investigation in murine model.
Nair GG; Nair CK
J Cancer Res Ther; 2014; 10(4):979-84. PubMed ID: 25579540
[TBL] [Abstract][Full Text] [Related]
5. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-mediated delivery of a rapidly activatable prodrug of SN-38 for neuroblastoma therapy.
Alferiev IS; Iyer R; Croucher JL; Adamo RF; Zhang K; Mangino JL; Kolla V; Fishbein I; Brodeur GM; Levy RJ; Chorny M
Biomaterials; 2015 May; 51():22-29. PubMed ID: 25770994
[TBL] [Abstract][Full Text] [Related]
7. Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1.
Tuttle TM; Inge TH; Bethke KP; McCrady CW; Pettit GR; Bear HD
Cancer Res; 1992 Feb; 52(3):548-53. PubMed ID: 1732041
[TBL] [Abstract][Full Text] [Related]
8. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
[TBL] [Abstract][Full Text] [Related]
9. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
10. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
Wang Y; Guo M; Lu Y; Ding LY; Ron WT; Liu YQ; Song FF; Yu SQ
Nanotechnology; 2012 Dec; 23(49):495103. PubMed ID: 23149859
[TBL] [Abstract][Full Text] [Related]
11. SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery.
Monterrubio C; Pascual-Pasto G; Cano F; Vila-Ubach M; Manzanares A; Schaiquevich P; Tornero JA; Sosnik A; Mora J; Carcaboso AM
Biomaterials; 2016 Feb; 79():69-78. PubMed ID: 26695118
[TBL] [Abstract][Full Text] [Related]
12. Expression of low levels of peripheral lymph node-associated vascular addressin in mucosal lymphoid tissues: possible relevance to the dissemination of passaged AKR lymphomas.
Bargatze RF; Streeter PR; Butcher EC
J Cell Biochem; 1990 Apr; 42(4):219-27. PubMed ID: 2187888
[TBL] [Abstract][Full Text] [Related]
13. CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells.
Ponzio NM; Cutro S; Hu J; Marzouk A; Marshall JD
Int Immunopharmacol; 2006 Dec; 6(13-14):2057-68. PubMed ID: 17161362
[TBL] [Abstract][Full Text] [Related]
14. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
[TBL] [Abstract][Full Text] [Related]
15. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
16. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response.
Thomas SN; Vokali E; Lund AW; Hubbell JA; Swartz MA
Biomaterials; 2014 Jan; 35(2):814-24. PubMed ID: 24144906
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.
Lu H; Li B; Kang Y; Jiang W; Huang Q; Chen Q; Li L; Xu C
Cancer Chemother Pharmacol; 2007 Feb; 59(2):175-81. PubMed ID: 16718469
[TBL] [Abstract][Full Text] [Related]
18. Effective conversion of irinotecan to SN-38 after intratumoral drug delivery to an intracranial murine glioma model in vivo. Laboratory investigation.
Wang W; Ghandi A; Liebes L; Louie SG; Hofman FM; Schönthal AH; Chen TC
J Neurosurg; 2011 Mar; 114(3):689-94. PubMed ID: 20415520
[TBL] [Abstract][Full Text] [Related]
19. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
[TBL] [Abstract][Full Text] [Related]
20. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q
ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]